Diamond Biofund Inc. (6901.TW)

44.15 +1.90 (+4.50%) At close: 01:30PM CST

Diamond Biofund Inc.

34th Floor
No. 66 Sec. 1, Zhongxiao W. Road Zhongzheng Distirct
Taipei 100
Taiwan
886 2 2703 1338
https://www.diamondbiofund.com/tc/index.htm

Sector(s): Financial Services
Industry: Asset Management
Full-time employees: 28

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Kung-Ming Lu	Founder & Chairman of the Board	N/A	N/A	N/A
Ms. Youmei Wu	President and General Manager	N/A	N/A	N/A
Mr. Yuan-Ting Wu	Head of the Finance Department & Acting CFO	N/A	N/A	N/A
Mr. Rex Lin	Investor Relations Professional	N/A	N/A	N/A
Mr. Dawei Ren	Investment Manager	N/A	N/A	N/A
Mr. Yen Cheng Huang	Vice President	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.

Corporate governance

Diamond Biofund Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.